Combo Immunotherapy Ups Survival in Advanced Liver Cancer

Overall survival, but not progression - free survival, improved with tremelimumab plus durvalumab versus sorafenib for unresectable HCC
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pharmacy, Conference News, Source Type: news